Quantum BioPharma Ltd. (CSE:QNTM)

Canada flag Canada · Delayed Price · Currency is CAD
31.50
-1.75 (-5.26%)
Aug 13, 2025, 4:00 PM EDT
169.23%
Market Cap 120.20M
Revenue (ttm) n/a
Net Income (ttm) -36.85M
Shares Out 3.82M
EPS (ttm) -16.79
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 9,863
Average Volume 4,289
Open 33.57
Previous Close 33.25
Day's Range 31.50 - 34.34
52-Week Range 3.90 - 52.00
Beta 1.62
RSI 49.23
Earnings Date Aug 13, 2025

About Quantum BioPharma

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 17
Stock Exchange Canadian Securities Exchange
Ticker Symbol QNTM
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.